CEL-SCI
CVMCel-Sci Corporation (NYSE American: CVM), is a biotechnology company that is testing drugs for the treatment of cancer, autoimmune and infectious diseases through the research and development of immunotherapy products. Cel-Sci's main product is the drug Multikine, an immunotherapeutic agent designed …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at CEL-SCI
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 1/22/2026 | Buy | Kersten, Geert R. | Chief Executive Officer | $5.3 | $200,001 |
| 12/4/2025 | Buy | Kersten, Geert R. | Chief Executive Officer | $6.0 | $49,998 |
| 7/25/2025 | Buy | Kersten, Geert R. | Chief Executive Officer | $6.9 | $199,999 |
| 7/25/2025 | Buy | Watson, Robert Eugene | Director | $6.9 | $19,995 |
| 5/8/2024 | Buy | Kersten, Geert R. | Chief Executive Officer | $1.4 | $41,700 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)